Treace Medical Concepts

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$50,214
$47,387
$52,570
$68,708
Gross Profit
39,706
37,752
41,893
55,477
EBITDA
-12,172
-13,501
-12,150
3,050
EBIT
-14,950
-16,077
-14,611
813
Net Income
-16,288
-17,398
-15,922
-501
Net Change In Cash
50,214
47,387
52,570
68,708
Free Cash Flow
-11,901
-7,817
655
-7,281
Cash
7,686
8,052
13,372
11,350
Basic Shares
63,515
63,006
62,661
62,340

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$209,357
$187,118
$141,838
$94,419
Gross Profit
168,264
151,937
114,315
77,531
EBITDA
-42,068
-39,008
-36,284
-15,807
EBIT
-50,487
-44,360
-38,417
-16,492
Net Income
-55,743
-49,527
-42,815
-20,552
Net Change In Cash
209,357
187,118
141,838
94,419
Cost of Revenue
-86,360
87,754
Free Cash Flow
-48,760
-46,033
-45,486
-19,898
Cash
11,350
12,982
19,473
105,833
Basic Shares
62,112
60,852
55,276
54,181

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.26
2025-06-30
-$0.28
2025-03-31
-$0.24